🇺🇸 FDA
Patent

US 8163772

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide

granted A61KA61K31/47A61K45/06

Quick answer

US patent 8163772 (Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
56
CPC classes
A61K, A61K31/47, A61K45/06, A61P, A61P11/00